Substrates for peptidase A02.009: Mason-Pfizer leukemia virus retropepsin

Summary Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates

Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.

Substrate Uniprot Residue range Cleavage Site Cleavage type Evidence P4 P3 P2 P1 P1' P2' P3' P4' Reference CutDB MERNUM
Ala-His-Gln-Val-Tyr+Nph-Val-Arg-Lys-Ala Ala-His-Gln-Val-Tyr-Nph-Val-Arg-Lys-Ala S His Gln Val Tyr Nph Val Arg Lys
Ala-Thr-Pro-Gln-Val-Tyr-Nph-Val-Arg-Lys-Ala Ala-Thr-Pro-Gln-Val-Tyr+Nph-Val-Arg-Lys-Ala S Pro Gln Val Tyr Nph Val Arg Lys Pichov, 2004
gag polyprotein P07567 2-657 peptide-Met100+Ala-peptide P Pro Gln Val Met Ala Ala Val Ala Pichov, 2004 15987
gag polyprotein P07567 2-657 peptide-Tyr621+Gly-peptide P Lys Gln Ala Tyr Gly Ala Val Ser Pichov, 2004 15990
gag polyprotein P07567 2-657 peptide-Phe299+Pro-peptide P Lys Asp Ile Phe Pro Val Thr Glu Pichov, 2004 15989
gag polyprotein P07567 2-657 peptide-Met216+Ala-peptide P Pro Thr Val Met Ala Val Val Asn Pichov, 2004 15988
Val-Ser-Ala-Asn-Tyr-Pro-Ile-Val-Gln peptide-Tyr5+Pro-peptide N AA Ser Ala Asn Tyr Pro Ile Val Gln Eizert et al., 2008
Val-Ser-Gln-Asn-Leu-Pro-Ile-Val-Gln peptide-Leu5+Pro-peptide N AA Ser Gln Asn Leu Pro Ile Val Gln Eizert et al., 2008
Val-Ser-Gln-Asn-Met-Pro-Ile-Val-Gln peptide-Met5+Pro-peptide N AA Ser Gln Asn Met Pro Ile Val Gln Eizert et al., 2008
Val-Ser-Gln-Asn-Phe-Pro-Ile-Val-Gln peptide-Phe5+Pro-peptide N AA Ser Gln Asn Phe Pro Ile Val Gln Eizert et al., 2008
Val-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln peptide-Tyr5+Pro-peptide N AA Ser Gln Asn Tyr Pro Ile Val Gln Eizert et al., 2008
Val-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln peptide-Tyr5+Pro-peptide N AA Ser Gln Asn Tyr Pro Ile Val Gln Eizert et al., 2008
Val-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln peptide-Tyr5+Pro-peptide N AA Ser Gln Asn Tyr Pro Ile Val Gln Eizert et al., 2008
Val-Ser-Gly-Asn-Tyr-Pro-Ile-Val-Gln peptide-Tyr5+Pro-peptide N AA Ser Gly Asn Tyr Pro Ile Val Gln Eizert et al., 2008
Val-Ser-Leu-Asn-Tyr-Pro-Ile-Val-Gln peptide-Tyr5+Pro-peptide N AA Ser Leu Asn Tyr Pro Ile Val Gln Eizert et al., 2008
Val-Ser-Lys-Asn-Tyr-Pro-Ile-Val-Gln peptide-Tyr5+Pro-peptide N AA Ser Lys Asn Tyr Pro Ile Val Gln Eizert et al., 2008
Val-Ser-Phe-Asn-Tyr-Pro-Ile-Val-Gln peptide-Tyr5+Pro-peptide N AA Ser Phe Asn Tyr Pro Ile Val Gln Eizert et al., 2008
Val-Ser-Val-Asn-Tyr-Pro-Ile-Val-Gln peptide-Tyr5+Pro-peptide N AA Ser Val Asn Tyr Pro Ile Val Gln Eizert et al., 2008